欧洲功能基因组市场：分析与预测（2023-2033）

2023年欧洲功能基因组市场规模为30.1亿美元。

预计2033年市场规模将达106.9亿美元，2023-2033年预测期间复合年增长率为13.52%。功能基因组学市场有望成长，主要是由于应用不断扩大，特别是在标靶治疗和精准医学领域。

由于基因组研究的进步和对个人化医疗的需求不断增加，欧洲功能基因组市场正在经历显着增长。功能基因组学是研究基因如何相互作用以及与环境相互作用以了解生物功能的学科。欧洲在生物技术和生命科学领域的强大实力以及在研发方面的大量投资导致了旨在阐明该地区疾病机制和开发标靶治疗的基因组研究激增。此外，学术机构、生物技术公司和政府机构之间的合作正在促进创新并支持市场扩张。此外，高通量定序和基因编辑技术的日益采用也进一步推动了功能基因组学市场的发展。随着欧洲在基因组学研究方面继续处于领先地位，功能基因组学市场正在持续成长，为医疗保健和生物技术的进步提供了充满希望的机会。

该报告考察了欧洲功能基因组学市场，提供了市场概述、各国趋势以及进入市场的公司概况。

目录

执行摘要

第一章 市场

• 产品定义
• 纳入与排除标准
• 市场范围
• 调查方法

第二章 市场概况

• 功能基因体学工作流程分析
• 未来性
• 功能基因体学的影响
  • 基因治疗
  • 药物研发发现与开发
  • 基因表现
  • 单细胞分析

第三章 区域

• 概述
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 其他地区

第四章 公司简介

• F. Hoffmann-La Roche Ltd
• Merck KGaA
• QIAGEN

The Europe Functional Genomics Market Expected to Reach $10.69 Billion by 2033

Introduction to Europe Functional Genomics Market

In 2023, the Europe functional genomics market was valued at $3.01 billion, and it is expected to reach $10.69 billion by 2033, growing at a CAGR of 13.52% during the forecast period 2023-2033. The functional genomics market is poised for growth, primarily propelled by its expanding applications, particularly in the realms of targeted therapy and precision medicine.

Market Introduction

The functional genomics market in Europe is experiencing notable growth driven by advancements in genomic research and rising demand for personalized medicine. Functional genomics involves studying how genes interact with each other and the environment to understand biological functions. With Europe's strong presence in biotechnology and life sciences, coupled with significant investments in research and development, the region is witnessing a surge in genomic studies aimed at unraveling disease mechanisms and developing targeted therapies. Moreover, collaborations between academic institutions, biotech companies, and government agencies are fostering innovation and driving market expansion. Additionally, increasing adoption of high-throughput sequencing and gene editing technologies further propels the functional genomics market. As Europe continues to lead in genomic research, the functional genomics market is poised for continued growth, offering promising opportunities for advancements in healthcare and biotechnology.

Market Segmentation:

Segmentation 1: by Country

• Germany
• France
• U.K.
• Italy
• Spain
• Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report considers functional genomics kits and assays-based companies. The industry is seeing constant development and product launches with new and innovative upgrades. Additionally, new discoveries of more efficient instruments and tools of functional genomics are increasing researchers' trust in functional genomics.

Growth/Marketing Strategy: The key components in Europe functional genomics are the kits and assays along with the instruments for sample analysis. The advancements in the overall functional genomics ecosystem are influencing the growth of this market.

Competitive Strategy: The key players in the Europe functional genomics market have been analyzed and profiled in the study, consisting of most product-based companies. Moreover, a detailed competitive benchmarking of the players operating in the Europe functional genomics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

• F. Hoffmann-La Roche Ltd
• Merck KGaA
• QIAGEN

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
• 1.2 Inclusion and Exclusion Criteria
• 1.3 Market Scope
  • 1.3.1 Scope of the Study
  • 1.3.2 Key Questions Answered in the Report
• 1.4 Research Methodology
  • 1.4.1 Functional Genomics Market: Research Methodology
  • 1.4.2 Data Sources
  • 1.4.3 Market Estimation Model
  • 1.4.4 Criteria for Company Profiling

2 Market Overview

• 2.1 Functional Genomics Workflow Analysis
• 2.2 Future Potential
• 2.3 Impact of Functional Genomics
  • 2.3.1 Gene Therapy
  • 2.3.2 Drug Discovery and Development
  • 2.3.3 Gene Expression
  • 2.3.4 Single-Cell Analysis

3 Region

• 3.1 Overview
• 3.2 Europe
  • 3.2.1 Germany
  • 3.2.2 France
  • 3.2.3 U.K.
  • 3.2.4 Italy
  • 3.2.5 Spain
  • 3.2.6 Rest-of-Europe

4 Company Profiles

• 4.1 Overview
• 4.2 F. Hoffmann-La Roche Ltd
  • 4.2.1 Company Overview
  • 4.2.2 Role of F. Hoffmann-La Roche Ltd in the Functional Genomics Market
  • 4.2.3 Financials
  • 4.2.4 Key Insights about the Financial Health of the Company
  • 4.2.5 Recent Developments
  • 4.2.6 Analyst Perspective
• 4.3 Merck KGaA
  • 4.3.1 Company Overview
  • 4.3.2 Role of Merck KGaA in the Functional Genomics Market
  • 4.3.3 Financials
  • 4.3.4 Key Insights about the Financial Health of the Company
  • 4.3.5 Analyst Perspective
• 4.4 QIAGEN
  • 4.4.1 Company Overview
  • 4.4.2 Role of QIAGEN in the Functional Genomics Market
  • 4.4.3 Financials
  • 4.4.4 Key Insights about the Financial Health of the Company
  • 4.4.5 Recent Developments
  • 4.4.6 Analyst Perspective

List of Figures

• Figure 1: Europe Functional Genomics Market, $Billion, 2023 and 2033
• Figure 2: Biological Features of Functional Genomics Approaches
• Figure 3: Share of Functional Genomics Market (by Region), 2022
• Figure 4: Functional Genomics Market: Research Methodology
• Figure 5: Primary Research Methodology
• Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 7: Top-Down Approach (Segment-Wise Analysis)
• Figure 8: Epigenomics Workflow
• Figure 9: Transcriptomics Workflow
• Figure 10: Proteomics Workflow
• Figure 11: Metabolomics Workflow
• Figure 12: Functional Genomics Market Snapshot (by Region)
• Figure 13: Functional Genomics Market (by Region), $Billion, 2023-2033
• Figure 14: Europe Functional Genomics Market, $Billion, 2022-2033
• Figure 15: Europe Functional Genomics Market (by Country), $Billion, 2022-2033
• Figure 16: Germany Functional Genomics Market, $Billion, 2022-2033
• Figure 17: France Functional Genomics Market, $Billion, 2022-2033
• Figure 18: U.K. Functional Genomics Market, $Billion, 2022-2033
• Figure 19: Italy Functional Genomics Market, $Billion, 2022-2033
• Figure 20: Spain Functional Genomics Market, $Billion, 2022-2033
• Figure 21: Rest-of-Europe Functional Genomics Market, $Billion, 2022-2033
• Figure 22: Functional Genomics Market, Total Number of Key Companies Profiled
• Figure 23: F. Hoffmann-La Roche Ltd: Product Portfolio
• Figure 24: F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
• Figure 25: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
• Figure 26: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
• Figure 27: Merck KGaA: Product Portfolio
• Figure 28: Merck KGaA: Overall Financials, $Million, 2020-2022
• Figure 29: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
• Figure 30: Merck KGaA: Revenue (by Region), $Million, 2020-2022
• Figure 31: Merck KGaA: R&D Expenditure, $Million, 2020-2022
• Figure 32: QIAGEN.: Product Portfolio
• Figure 33: QIAGEN: Overall Financials, $Million, 2019-2021
• Figure 34: QIAGEN: Revenue (by Segment), $Million, 2019-2021
• Figure 35: QIAGEN: Revenue (by Region), $Million, 2019-2021
• Figure 36: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021

List of Tables

• Table 1: Europe Functional Genomics Market: Impact Analysis
• Table 2: Technological Trends in Functional Genomics Market
• Table 3: Europe: Market Dynamics